Glucagon and type 2 diabetes: the return of the alpha cell

Keyphrases

• Alpha Cell 100%
• Antagonization 33%
• B Cells 33%
• Effective Treatment 33%
• Gastrointestinal Hormones 33%
• Glucagon 100%
• Glucagon Receptor 66%
• Glucagon Secretion 100%
• Glucagon-like 33%
• Glucose Homeostasis 33%
• Glucose-dependent Insulinotropic Polypeptide 66%
• Hepatic Glucose Production 66%
• Hyperglucagonemia 66%
• Hyperglycemia 33%
• Incretin Hormones 33%
• Insulin 33%
• Normal Physiology 33%
• Pancreatic α-cell 33%
• Regulatory Effect 33%
• Treatment Strategy 33%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Type 2 Diabetic 33%
• Type 2 Diabetic Patients 100%

Medicine and Dentistry

• Beta Cell 33%
• Clinical Study 33%
• Diabetes Mellitus 33%
• Effective Treatment 33%
• Gastric Inhibitory Polypeptide 66%
• Gastrointestinal Hormone 33%
• Glucagon 100%
• Glucagon Like Peptide 1 33%
• Glucagon Receptor 66%
• Glucagon Release 100%
• Gluconeogenesis 66%
• Glucose Homeostasis 33%
• Hyperglucagonemia 66%
• Hyperglycemia 33%
• Incretin 33%
• Insulin 33%
• Maturity Onset Diabetes of the Young 100%
• Pathophysiology 33%
• Patient with Type 2 Diabetes 100%
• Physiology 33%

Biochemistry, Genetics and Molecular Biology

• Clinical Study 25%
• Gastric Inhibitory Polypeptide 50%
• Gastrointestinal Hormone 25%
• Glucagon 100%
• Glucagon Receptor 50%
• Glucagon Release 75%
• Glucagon-Like Peptide-1 25%
• Gluconeogenesis 50%
• Glucose Homeostasis 25%
• Hyperglycemia 25%
• Incretin 25%
• Insulin 25%
• Maturity Onset Diabetes of the Young 100%